Sponsorships

This interactive portal allows you to:

• provide necessary information so ADCT may appropriately evaluate your request
• track the status of your request

If your request does not fall under one of the mentioned categories please refer to the following portal or reach out through our contact form:

• Charitable Contributions/Donations
• Sponsorships/Corporate or State Memberships/Patient Advocacy Grants

Independent Continuing Medical Education Grants

ADC Therapeutics supports independent Continuing Medical Education (CME) grants to support educational activities and programs that assist healthcare professionals in enhancing the care of their patients. ADC Therapeutics’ current area of therapeutic interest is relapsed/refractory diffuse large B-cell lymphoma.

ADC Therapeutics defines a CME grant as a type of grant which consists of funding for activities or initiatives that serve to maintain, develop, or increase the knowledge, skills, and/or professional performance of a healthcare professional (e.g., continuing medical education, continuing health education). These activities may or may not be accredited. The program and content are always decided independently from industry supporters. Likewise, the audience is identified and invited by the recipient organization and not by industry supporters.

The CME grant submission process is done via an interactive portal allowing all requests to come into ADC Therapeutics via a simple, user-friendly website. The portal provides information required to successfully complete your submission and transparently enables you to track the grant’s progress through governance review.

The Grants Review Committee meets regularly to review requests. The status of an individual request is available on the CME grants portal.

Investigator Initiated Trials

ADC Therapeutics and our partners accept unsolicited proposals requesting support to conduct Investigator Initiated Trials (IITs) for our products. Proposals must align with ADC Therapeutics’ strategic areas of interest, including but not limited to:

• Clinical interventions assessing unmet medical needs, novel combinations, new indications, and various patient populations in therapeutic areas of interest
• Non-interventional studies
• Translational and observational studies

Investigators can submit and track the progress of their proposals through the IIT portal. Proposals are reviewed for scientific merit as well as compliance with legal, ethical, and professional obligation prior to endorsement.

Please submit IIT proposals to our partner Sobi for those proposed outside of the United States, excluding Greater China, Singapore and Japan, via their portal.